Cargando…

A New Interpretation of the Standard PSA-Test

BACKGROUND: In Puerto Rico, prostate cancer (PC) has the highest incidence and level of mortality. PC screening is performed using the standard prostatic-specific antigen (PSA) test with a cut-off value of 4.0 ng/mL. However, the standard PSA test is very controversial because it is subject to false...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteban, Ernesto P, Almodovar-Abreu, Lusmeralis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060028/ https://www.ncbi.nlm.nih.gov/pubmed/32185150 http://dx.doi.org/10.2147/RRU.S240171

Ejemplares similares

Assessing the impact of vaccination in a COVID-19 compartmental model
por: Esteban, Ernesto P., et al.
Publicado: (2021)

Is serum PSA a predictor of male hypogonadism? Testing the hypothesis
por: Amadi, Collins, et al.
Publicado: (2021)

Temperature Control of psaA Expression by PsaE and PsaF in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2019)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Corrosion tests and standards: application and interpretation
por: Baboian, Robert
Publicado: (1995)

Molecular Form Differences Between Prostate-Specific Antigen (PSA) Standards Create Quantitative Discordances in PSA ELISA Measurements
por: McJimpsey, Erica L.
Publicado: (2016)

Role of PSA Density and MRI in PSA Interpretation. Comment on Lumbreras et al. Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data. Cancers 2023, 15, 261
por: Jue, Joshua S., et al.
Publicado: (2023)

Comparison of clinical antibiotic susceptibility testing interpretations to CLSI standard interpretations
por: Hitchingham, Erin, et al.
Publicado: (2023)

Establishment of reference intervals for serum [−2]proPSA (p2PSA), %p2PSA and prostate health index in healthy men
por: Wu, Zhi-Yu, et al.
Publicado: (2019)

Survey of the rate of PSA testing in general practice
por: Melia, J, et al.
Publicado: (2001)

Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP)
por: Thorn, Joanna C., et al.
Publicado: (2023)

A Comparative Performance Analysis of Total PSA, Percentage Free PSA, PSA Velocity, and PSA Density versus the Detection of Primary Circulating Prostate Cells in Predicting Initial Prostate Biopsy Findings in Chilean Men
por: Murray, Nigel P., et al.
Publicado: (2014)

Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
por: Strittmatter, F, et al.
Publicado: (2011)

Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
por: Frasca, Loredana, et al.
Publicado: (2018)

The Relationship between Prostate Biopsy Results and PSA and Free PSA Ratio Changes in Elevated Serum PSA Patients with and without Antibiotherapy
por: Duran, Mesut Berkan, et al.
Publicado: (2020)

Galectin-3: a possible complementary marker to the PSA blood test
por: Balan, Vitaly, et al.
Publicado: (2013)

Urinary PSA and Serum PSA for Aggressive Prostate Cancer Detection
por: Höti, Naseruddin, et al.
Publicado: (2023)

Reply to Jue, J.S.; Alameddine, M. Role of PSA Density and MRI in PSA Interpretation. Comment on “Lumbreras et al. Variables Associated with False-Positive PSA Results: A Cohort Study with Real-World Data. Cancers 2023, 15, 261”
por: Lumbreras, Blanca, et al.
Publicado: (2023)

Zonal adjusted PSA density improves prostate cancer detection rates compared with PSA in Taiwanese males with PSA < 20 ng/ml
por: Chang, Tsung-Hsin, et al.
Publicado: (2020)

Time to PSA rise differentiates the PSA bounce after HDR and LDR brachytherapy of prostate cancer
por: Burchardt, Wojciech, et al.
Publicado: (2018)

Association of Polymorphisms in the Prostate-Specific Antigen (PSA) Gene Promoter with Serum PSA Level and PSA Changes after Dutasteride Treatment in Korean Men with Benign Prostatic Hypertrophy
por: Park, Sung Woon, et al.
Publicado: (2010)

Free PSA performs better than total PSA in predicting prostate volume in Chinese men with PSA levels of 2.5–9.9 ng ml(−1)
por: Huang, Ma-Ping, et al.
Publicado: (2022)

Routine PSA Testing: An Analysis of the Controversy Concerning Its Use
por: Hussain, Namath S.
Publicado: (2005)

Assessing Diagnostic Tests: How to Correct for the Combined Effects of Interpretation and Reference Standard
por: Omurtag, Ahmet, et al.
Publicado: (2012)

Does normalizing PSA after successful treatment of chronic prostatitis with high PSA value exclude prostatic biopsy?
por: Azab, Sherif, et al.
Publicado: (2012)

Antigenic determinants of prostate-specific antigen (PSA) and development of assays specific for different forms of PSA.
por: Nilsson, O., et al.
Publicado: (1997)

Nadir PSA level and time to nadir PSA are prognostic factors in patients with metastatic prostate cancer
por: Tomioka, Atsushi, et al.
Publicado: (2014)

Evaluation of a rapid one-step PSA test for primary prostate cancer screening
por: Ashida, Shingo, et al.
Publicado: (2021)

PSA screening – for whom and when?
por: Albers, Peter
Publicado: (2019)

Predictors of Repeated PSA Testing Among Black and White Men From the Maryland Cancer Survey, 2006
por: Zhu, Yue, et al.
Publicado: (2011)

The PSA testing dilemma: GPs' reports of consultations with asymptomatic men: a qualitative study
por: Clements, Alison, et al.
Publicado: (2007)

Yinglu Guo: PSA screening test requires wider application in China
por: Song, Xiaoping
Publicado: (2012)

PsaF Is a Membrane-Localized pH Sensor That Regulates psaA Expression in Yersinia pestis
por: Quinn, Joshua D., et al.
Publicado: (2021)

Significance of PSA Screening in Niigata, Japan: Survey of Actual Status of New Cases of Prostate Cancer
por: Saito, Toshihiro, et al.
Publicado: (2021)

Assessment of the many faces of PsA: single and composite measures in PsA clinical trials
por: McGagh, Dylan, et al.
Publicado: (2020)

Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA
por: Seo, Hyung Seok, et al.
Publicado: (2010)

Relationship between initial PSA density with future PSA kinetics and repeat biopsies in men with prostate cancer on active surveillance
por: Kotb, A F, et al.
Publicado: (2011)

Is the new interpretation of some standard CPT-violation parameters necessary?
por: Urbanowski, K
Publicado: (1994)

Exploration of the Value of Combined UA, IL-6, and fPSA/tPSA in the Diagnosis of Prostate Cancer
por: Tang, Qionghua, et al.
Publicado: (2022)

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience
por: Murgic, Jure, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a384u1nhflbdgc2eku1nfufedm